Your browser is no longer supported. Please, upgrade your browser.
LLY Eli Lilly and Company daily Stock Chart
Eli Lilly and Company
IndexS&P 500 P/E48.35 EPS (ttm)1.62 Insider Own11.40% Shs Outstand1.07B Perf Week-0.99%
Market Cap84.01B Forward P/E14.78 EPS next Y5.30 Insider Trans-0.55% Shs Float1.07B Perf Month-0.76%
Income1.71B PEG4.04 EPS next Q1.14 Inst Own79.70% Short Float1.12% Perf Quarter-9.44%
Sales22.87B P/S3.67 EPS this Y-37.00% Inst Trans0.90% Short Ratio2.54 Perf Half Y-5.03%
Book/sh11.11 P/B7.05 EPS next Y8.74% ROA-0.50% Target Price91.24 Perf Year-6.77%
Cash/sh7.50 P/C10.46 EPS next 5Y11.98% ROE-1.50% 52W Range73.69 - 89.09 Perf YTD-7.21%
Dividend2.25 P/FCF35.80 EPS past 5Y-15.00% ROI6.60% 52W High-12.03% Beta0.26
Dividend %2.87% Quick Ratio1.00 Sales past 5Y0.20% Gross Margin73.50% 52W Low6.35% ATR1.60
Employees40655 Current Ratio1.30 Sales Q/Q6.90% Oper. Margin9.40% RSI (14)46.33 Volatility1.97% 1.85%
OptionableYes Debt/Eq1.18 EPS Q/Q-66.00% Profit Margin-0.90% Rel Volume0.82 Prev Close78.73
ShortableYes LT Debt/Eq0.86 EarningsJan 31 BMO Payout- Avg Volume4.74M Price78.37
Recom2.30 SMA200.08% SMA50-3.04% SMA200-5.25% Volume3,896,498 Change-0.46%
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Mar-20-17Reiterated UBS Neutral $70 → $85
Dec-16-16Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-27-16Upgrade Goldman Neutral → Buy
Sep-08-16Upgrade JP Morgan Neutral → Overweight
May-02-16Reiterated Leerink Partners Outperform $96 → $101
Apr-06-16Initiated Societe Generale Hold $78
Dec-28-15Reiterated Leerink Partners Outperform $93 → $95
Dec-07-15Upgrade Deutsche Bank Hold → Buy $85 → $99
Dec-01-15Upgrade Barclays Equal Weight → Overweight $75 → $95
Nov-12-15Reiterated Leerink Partners Outperform $90 → $93
Oct-09-15Upgrade Credit Suisse Neutral → Outperform
Sep-21-15Reiterated JP Morgan Neutral $83 → $90
Mar-21-18 12:25AM  CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business The Wall Street Journal
Mar-20-18 05:16PM  CVS appoints former Eli Lilly CFO as president of PBM business Reuters
10:02AM  CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business The Wall Street Journal
06:00AM  3 High-Quality Dividend-Payers Selling at a Discount Morningstar
Mar-19-18 12:39PM  Qualcomm Ex-Chairman's Leveraged Buyout Bid a Real Long Shot
Mar-16-18 09:45AM  Is Eli Lilly and Company (LLY) Stock a Good Value Pick Now? Zacks
Mar-15-18 08:47AM  How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment Motley Fool
06:29AM  Capitol to Capital: Cramer's 'Mad Money' Recap (Wednesday 3/14/18)
Mar-14-18 07:03PM  Cramer's lightning round: Hidden giant Cintas is one of m... CNBC Videos
09:02AM  Your first trade for Wednesday, March 14 CNBC
Mar-13-18 05:59PM  "Fast Money" final trades: TGT, GLD and more CNBC Videos
03:28PM  Eli Lilly Pleased With Uptake for Breast Cancer Drug Verzenio, Says Exec
Mar-12-18 05:55PM  East Bay company's stock plummets 81% as drug for cystic fibrosis patients fails American City Business Journals
09:05AM  The Zacks Analyst Blog Highlights: Coca-Cola, Eli Lilly, Occidental Petroleum, Ross Stores and Wynn Resorts Zacks
Mar-09-18 03:22PM  Top Stock Reports for Coca-Cola, Eli Lilly & Occidental Petroleum Zacks
08:59AM  Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology PR Newswire
07:45AM  Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails Zacks
Mar-08-18 06:30AM  EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research PR Newswire
06:01AM  Lilly, Boehringer to Expand Jardiance Heart Failure Program Zacks
Mar-07-18 04:00PM  Pharmaceutical Industry Outlook - March 2018 Zacks
06:33AM  2 Undervalued Innovators in Big Pharma Morningstar
Mar-06-18 12:30PM  Are Alzheimer's-Focused Stocks Set for a Financial Windfall? Zacks
08:00AM  Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials PR Newswire
Mar-02-18 10:43AM  Why Is Eli Lilly (LLY) Down 7.2% Since its Last Earnings Report? Zacks
Feb-27-18 12:12PM  Eli Lilly Needs to Prove It Can Overcome Resistance Above $82
09:53AM  Lilly's Verzenio Wins FDA Nod for First Line Breast Cancer Zacks
08:14AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
Feb-26-18 05:13PM  Lilly breast cancer drug wins expanded U.S. approval Reuters
04:16PM  Lilly Receives Additional FDA Approval for VerzenioTM (abemaciclib), as Initial Treatment for Advanced Breast Cancer PR Newswire
06:45AM  New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes PR Newswire
Feb-23-18 03:28PM  Endo, Glaxo to Settle Suits Over Testosterone Drug Bloomberg
08:20AM  Todays Research Reports on Trending Tickers: InspireMD and Eli Lilly and Company ACCESSWIRE
Feb-21-18 01:48PM  [$$] Buying GE, Dumping GM, Cisco, DowDuPont, Lilly
12:30PM  Lilly to Participate in Barclays Global Healthcare Conference PR Newswire
11:52AM  Novo Nordisk gets nod from U.S. drug purchaser for new diabetes hope Reuters
07:30AM  New Research: Key Drivers of Growth for SpartanNash, Nustar GP, Hornbeck Offshore Services, TiVo, Eli Lilly, and Rigel Pharmaceuticals Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-20-18 06:48PM  Eli Lilly and Co (LLY) Files 10-K for the Fiscal Year Ended on December 31, 2017
03:30PM  Lilly to Participate in Cowen Health Care Conference PR Newswire
07:00AM  Survey Reveals Many People with Migraine Live with Pain Nearly Half of Every Month PR Newswire
06:02AM  Why This Is the Best Time in Years to Buy Eli Lilly Motley Fool
Feb-19-18 06:45AM  AAD 2018: Treatment with Lilly's Taltz® (ixekizumab) Resulted in Improvement in Impact of Genital Psoriasis on Sexual Activity PR Newswire
Feb-18-18 12:50PM  Biogens key Alzheimers disease drug is facing potential signs of trouble MarketWatch
Feb-16-18 07:01PM  Jim Cramer: Drug Stocks on the Move
02:01PM  Can Billion-Dollar Startups Be Created From Big Companies' Unused IP? Ex-Walgreens CEO Bets 'Yes' Forbes
10:18AM  Here's How Eli Lilly Stock Can Regain Its Footing
07:17AM  FDA Sets the Stage for Earlier-Stage Alzheimer's Treatments Zacks
Feb-15-18 04:33PM  Biogens key Alzheimers disease drug is facing potential signs of trouble MarketWatch
Feb-14-18 01:17PM  Lilly to Showcase New Data for Taltz® (ixekizumab) and Other Products Across Immunology Pipeline at AAD Annual Meeting PR Newswire
09:47AM  Merck (MRK) Halts Another Late Stage Study on Alzheimer's Zacks
09:47AM  Lilly's Taltz Positive in Phase III Label Expansion Study Zacks
07:50AM  Free Research Report as Eli Lillys Quarterly Revenue Jumped 6%; Adjusted EPS Jumped 20% ACCESSWIRE
Feb-13-18 05:42PM  Dodge & Cox Comments on Eli Lilly
05:27PM  Dodge & Cox 4th Quarter Commentary
08:18AM  Better Buy: Eli Lilly and Company vs. Johnson & Johnson Motley Fool
07:23AM  Eli Lilly's Taltz meets primary endpoint in late-state trial for AS treatment MarketWatch
06:45AM  Lilly Announces Positive Top-Line Phase 3 Results for Taltz® (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis) PR Newswire
Feb-12-18 08:28AM  [$$] Buying United, Selling Lilly, Rambus, Tronc
08:20AM  Todays Research Reports on Trending Tickers: Eli Lilly and Company and Pfizer ACCESSWIRE
Feb-11-18 10:19PM  Better Buy: Pfizer Inc. (PFE) vs. Eli Lilly (LLY) Motley Fool
Feb-10-18 03:55PM  Is Buying Eli Lilly and Company (NYSE:LLY) For Its Upcoming $0.56 Dividend A Good Choice? Simply Wall St.
Feb-09-18 11:00AM  Solid Q4 Earnings Drive Pharma ETF Outlook Zacks
Feb-08-18 02:34PM  Vanguard Health Care Fund's Largest Sales of the 4th Quarter
09:41AM  The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease Benzinga
09:09AM  Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices
08:20AM  Todays Research Reports on Trending Tickers: Eli Lilly and Company and InspireMD ACCESSWIRE
Feb-07-18 06:22PM  Read This Before Buying Eli Lilly and Company (NYSE:LLY) For Its Upcoming $0.56 Dividend Simply Wall St.
Feb-06-18 10:19AM  FOCUS-In diabetes war, Novo Nordisk aims to break mould with new pill Reuters
07:30AM  Free Post Earnings Research Report: AbbVies Q4 FY17 Results Beat Market Estimates ACCESSWIRE
Feb-05-18 06:52AM  5 Opioid Treatment Stocks Insider Monkey
Feb-04-18 11:53AM  [$$] New Rules Change How Research on Humans Is Disclosed The Wall Street Journal
Feb-03-18 08:00AM  Pharma Execs Talk M&A, Drug Pricing Pressures on Earnings Calls
Feb-01-18 08:28AM  [$$] DowDuPont Unit Dumps GE Stock, Buys Ford
Jan-31-18 05:21PM  U.S. public health chief quits over financial conflicts Reuters -5.39%
05:10PM  What Happened in the Stock Market Today Motley Fool
04:38PM  Expect more wild swings in the Dow in February: trader Yahoo Finance
04:33PM  Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks Investor's Business Daily
04:12PM  Dow, S&P 500 and Nasdaq Finish Higher After Up-and-Down Day of Trading
01:37PM  Eli Lilly Beats Estimates, but Shares Head Lower Amid Diabetes Concerns
01:19PM  Lilly beats estimates; shares fall on diabetes, animal health concerns Reuters
01:17PM  Eli Lilly Earnings: What It Said to Sink Its Stock
12:48PM  Lilly beats estimates; shares fall on diabetes, animal health concerns Reuters
12:47PM  Markets Rebound Bigly on ADP, Q4, SOTU Zacks
12:41PM  AbbVie Is Ruining Pharma Earnings Season Bloomberg
12:01PM  Eli Lilly CEO Welcomes Amazons Arrival in the Health Care Business Fortune
11:29AM  Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance Zacks
09:27AM  Eli Lilly CEO Ready to Put $9 Billion in Cash to Work Bloomberg Video
08:50AM  Eli Lilly Cruises Through Q4 Earnings 24/7 Wall St.
08:05AM  Stocks making the biggest moves premarket: BA, ANTM, ADP, LLY, AVY, XRX, EA & more CNBC
07:58AM  Eli Lilly (LLY) Tops Q4 Earnings & Sales, Ups 2018 View Zacks
07:17AM  Eli Lilly CEO: New products driving top line growth CNBC Videos
07:12AM  Lilly reports 4Q loss Associated Press
06:39AM  Eli Lilly posts fourth-quarter earnings beat, hikes 2018 guidance CNBC
06:37AM  Drugmaker Eli Lilly posts quarterly loss on tax charges Reuters
06:25AM  Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance PR Newswire
Jan-30-18 06:06PM  Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX Zacks
Jan-29-18 05:27PM  Alex Azar sworn in as secretary of Health and Human Services Associated Press
03:58PM  Will Azar Practice 'Art of the Deal' Capitalism at Trump's HHS? Forbes
03:58PM  Will Azar Practice "Art of the Deal" Capitalism at Trump's HHS? Forbes
10:52AM  PFE, LLY, MRK Write Up 'Scripts For Q4 Benzinga
10:42AM  Pfizer, Eli Lilly, Merck Earnings Preview: Big Pharma On Docket This Week Forbes
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; and Nektar Therapeutics. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smiley Joshua LSVP and CFOMar 16Sale79.203,000237,60020,029Mar 20 12:06 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale76.5086065,7901,637Mar 05 03:30 PM
Zakrowski Donald AChief Accounting OfficerFeb 21Sale77.5587667,9342,472Feb 23 05:42 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048048Feb 21 10:28 AM
Zakrowski Donald AChief Accounting OfficerFeb 05Sale81.0990072,9814,130Feb 05 06:39 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 05Sale81.129,625780,780133,201Feb 05 06:37 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 01Option Exercise0.0021,3260152,120Feb 05 06:37 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0015,993065,357Feb 05 06:33 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0021,3260140,809Feb 05 06:31 PM
Mahony SusanSVP & Pres., Lilly OncologyFeb 01Option Exercise0.0021,326060,350Feb 05 06:24 PM
Lundberg Jan MEVP,Science&Tech and Pres. LRLFeb 01Option Exercise0.0036,2520214,295Feb 05 06:21 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0024,5240102,738Feb 05 06:19 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0017,0600107,820Feb 05 06:15 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0021,3260147,980Feb 05 06:12 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.006,398022,107Feb 05 06:09 PM
LILLY ENDOWMENT INC10% OwnerDec 13Sale88.20200,00017,639,176123,075,804Dec 14 11:26 AM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthDec 11Sale86.4612,5001,080,750124,522Dec 13 03:01 PM
Zulueta Alfonso GSVP & President, Lilly Int'lDec 04Sale86.003,532303,75240,048Dec 05 05:35 PM
Mahony SusanSVP & Pres., Lilly OncologyDec 04Sale86.1836,5853,152,89554,885Dec 05 05:32 PM
Zakrowski Donald AChief Accounting OfficerDec 03Option Exercise0.003,28104,167Dec 05 05:48 PM
Fry Stephen FSVP, HR & DiversityDec 03Option Exercise0.007,557086,501Dec 05 05:46 PM
Ricks David APresident & CEODec 03Option Exercise0.005,4960110,059Dec 05 05:43 PM
Zulueta Alfonso GSVP & President, Lilly Int'lNov 10Sale83.672,003167,59143,580Nov 13 12:55 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale86.81205,00017,795,025123,275,804Oct 05 02:56 PM
LILLY ENDOWMENT INC10% OwnerSep 29Sale85.14195,00016,602,601123,480,804Oct 02 03:39 PM
LILLY ENDOWMENT INC10% OwnerSep 15Sale82.53190,00015,679,772123,675,804Sep 18 03:42 PM
LILLY ENDOWMENT INC10% OwnerAug 31Sale81.06180,00014,590,080123,865,804Sep 01 01:45 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale83.09220,00018,279,478124,045,804Aug 01 10:55 AM
LILLY ENDOWMENT INC10% OwnerJun 22Sale84.43210,00017,730,720124,265,804Jun 23 10:16 AM
LILLY ENDOWMENT INC10% OwnerJun 20Sale83.05215,00017,855,363124,475,804Jun 21 11:24 AM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMJun 12Sale80.781,900153,48214,041Jun 13 04:10 PM
Harrington Michael JSenior VP and General CounselJun 09Sale79.9722,8331,825,95562,056Jun 09 04:15 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 04Sale82.7625,0002,069,000114,217May 08 03:44 PM
LILLY ENDOWMENT INC10% OwnerMar 30Sale84.67210,00017,781,540124,690,804Mar 31 11:11 AM